Sunitinib is used as a targeted therapy and a receptor protein-tyrosine kinase inhibitor for advanced renal cell cancer and gastrointensinal stromal tumor (GIST). Sunitinib is marketed under the name Sutent. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
Related categories 1
Sites 4
Loading new listings for you to review...
- Rxlist: Sutent Medication description and FDA approved drug information including side effects, interactions and patient labeling.
- Chemocare: Sutent Provides drug description, side effects, and how the therapy works.
- Wikipedia: Sunitinib Description of targeted therapy drug includes indications for therapy and links.
- Sutent (sunitinib malate) Official site and information about using the drug in treatment for advanced renal cell carcinoma and gastrointestinal stromal tumor (GIST).